Research Review Australia

Bladder Cancer Research Review Issue 5, 2023 Issue 6, 2023 Issue 7, 2023 Issue 8, 2023 Issue 9, 2023 Issue 10, 2024 Issue 11, 2023 Issue 12, 2024 Issue 13, 2024 Issue 14, 2024 Issue 15, 2024 Issue 16, 2025 Issue 17, 2025
Conference Research Review USANZ 2023 Conference Review EAU 2023 Conference Review AUA 2023 Conference Review APCC 2023 Conference Review USANZ 2024 Conference Review EAU 2024 Conference Review ASCO 2024 Conference Review ANZUP 2024 Conference Review ASCO 2025 Conference Review ASCO Chicago 2025 Conference Review APCC 2025 Conference Review
Continence Research Review Issue 11, 2023 Issue 12, 2023 Issue 13, 2024
Product Review Product review: Enfortumab vedotin (PADCEV™) for the treatment of locally advanced or metastatic urothelial cancer
Prostate Cancer Practice Review Issue 11, 2023 Issue 12, 2023 Issue 13, 2023 Issue 14, 2023 Issue 15, 2023 Issue 16, 2023 Issue 17, 2023 Issue 18, 2023 Issue 20, 2024 Issue 21, 2024 Issue 22, 2024 Issue 24, 2024 Issue 25, 2024 Issue 27, 2025 Issue 28, 2025 Issue 29, 2025 Issue 30, 2025
Prostate Cancer Research Review Issue 64, 2023 Issue 65, 2023 Issue 66, 2023 Issue 67, 2023 Issue 68, 2023 Issue 69, 2023 Issue 70, 2023 Issue 71, 2023 Issue 72, 2023 Issue 73, 2024 Issue 74, 2024 Issue 75, 2024 Issue 76, 2024 Issue 77, 2024 Issue 78, 2024 Issue 79, 2024 Issue 80, 2024 Issue 81, 2024 Issue 82, 2024 Issue 83, 2024 Issue 84, 2025 Issue 85, 2025 Issue 86, 2025 Issue 88, 2025
Study Review Apalutamide plus ADT in metastatic castration-sensitive prostate cancer Real-World Effectiveness of Avelumab
Urology Practice Review Issue 10, 2023
Urology Research Review Issue 59, 2023 Issue 60, 2023 Issue 61, 2023 Issue 62, 2023 Issue 63, 2023 Issue 64, 2024 Issue 65, 2024 Issue 67, 2025

Latest Tweets
@USANZUrology

Membership Login